Navigation Links
Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer

SOUTH SAN FRANCISCO, Calif., April 03, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today announced final, updated results from its second multi-center Phase 2 trial of GVAX immunotherapy for prostate cancer which evaluated escalating doses of the immunotherapy in 80 patients with metastatic hormone-refractory prostate cancer (HRPC). Additional follow-up of the 22 patients who received the dose that is comparable to that being employed in the company's ongoing Phase 3 program indicates that the median survival is 35.0 months. Four patients have withdrawn consent to further follow-up and thus were censored in the analysis. The company previously reported final median survival results from its first multi-center Phase 2 trial of GVAX immunotherapy for prostate cancer in 34 patients with metastatic HRPC that showed an overall median survival of 26.2 months. The survival results from the two, independent multi-center Phase 2 clinical trials compare favorably to the previously published median survival of 18.9 months for metastatic hormone-refractory prostate cancer patients treated with Taxotere(R) (docetaxel) chemotherapy plus prednisone, the current standard of care for these patients. The company's ongoing Phase 3 program is designed to confirm this potential survival benefit for GVAX immunotherapy for prostate cancer.

"We are certainly encouraged by the survival data from the second Phase 2 trial of GVAX immunotherapy for prostate cancer. The final median survival of 35.0 months also compares favorably to a predicted median survival of 22.0 months for these 22 patients based on a validated, published nomogram using seven prognostic variables," stated Rob Dow, M.D., chief medical officer of Cell Genesys. "We continue to hope that GVAX immunotherapy for prostate cancer may some day offer a new treatment option for patients with this disease."

GVAX immunotherapy for prostate cancer is currently
'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
2. Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. XTL Provides Update on Phase I Clinical Trial of XTL-2125
5. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
6. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
7. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
8. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
9. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
10. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
11. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy

Post Your Comments:
(Date:11/6/2009)...ov. 6 Philips Respironics applauds...d Prevention (CDC) to raise awareness about an imp...iciency. The CDC,s release of the first-ever gover...in sleeplessness is a milestone in quantifying the...ime educator, industry leader and sleep therapy ma...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Keryx Biopharmaceuticals, ...on Tuesday, November 10, 2009 at 8:30 a.m. EST to ...nd business outlook for the remainder of 2009. Ro... will host the call. Keryx will announce its fina...o be issued prior to the call. ,, In order to p...
(Date:11/6/2009)...Newswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bul...n Atlanta-based, biopharmaceutical company develop...uman Immunodeficiency Virus) and other infectious ...ancial results and provided an operational update....Executive Officer commented, "We are pleased with ...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Study Urges Treatment for Even Mild Gestational Diabetes 58587 1Study Urges Treatment for Even Mild Gestational Diabetes 58587 2Study Urges Treatment for Even Mild Gestational Diabetes 58587 3TOPS Workplace Wellness Programs Can Improve Members 26apos 3B Health Employers 26apos 3B Bottom Line 58585 1TOPS Workplace Wellness Programs Can Improve Members 26apos 3B Health Employers 26apos 3B Bottom Line 58585 2TOPS Workplace Wellness Programs Can Improve Members 26apos 3B Health Employers 26apos 3B Bottom Line 58585 3Nicole Sullivan Joins Jenny Craig to Reclaim Her Pre Baby Body 58582 1Nicole Sullivan Joins Jenny Craig to Reclaim Her Pre Baby Body 58582 2
...l Experience about Protecting Kids from a Deadly ... WASHINGTON, Oct. 16 Parents of Kids with Infect...f its national educational,campaign "Silence the S...Russell. To view the Multimedia News Release, go .../ The campaign sounds the alarm about the danger...
...st Pharmaceutical,Services, Inc. (NYSE: WST ) tod...tors of Mr. Thomas W. Hofmann. Mr. Hofmann, 56, is... of Sunoco, Inc. (NYSE: SUN ), a,position he has ...lphia-based Sunoco is one of the largest independe...United States. Mr. Hofmann,also serves on the boar...
Other Medicine Technology:Video: Actress and New Mom Keri Russell Joins PKIDs to Launch 'Silence the Sounds of Pertussis' Campaign 2Video: Actress and New Mom Keri Russell Joins PKIDs to Launch 'Silence the Sounds of Pertussis' Campaign 3West Pharmaceutical Services, Inc. Appoints New Director 2
(Date:11/8/2009)... holds open house at Victoria campus , ...9 -- UCW Academy of Health invites anyone looking ...th care industry to attend their open house in Vic...demy of Health, which offers diplomas in areas suc...designs its programs to meet the needs of the heal...
(Date:11/8/2009).../ -- Speaker Nancy Pelosi and Democratic leaders h... of H.R. 3962, the Affordable Health Care for Amer... Below are the Speaker,s opening remarks: ,, ...from the President of the United States, Barack Ob...American people. I thank the President for his tre...
(Date:11/8/2009)...s pleased to announce that it has been successful ...d who recently received an award on the $800 milli...udes not only the Veterans Administration, but als...cies. , New York, NY (PRW...ased to announce that it has been successful in pr...
(Date:11/8/2009)... the Western District of Pennsylvania award a Faye...for a medical malpractice case. Attorneys Thomas ... E. Crenney and Associates, LLC handled the case o...ainst the Uniontown Hospital. The woman had to ha...e 18. , Pittsburgh, PA(PR...
(Date:11/8/2009)...lth advocates committed to achieving meaningful he... "Tonight the U.S. Hous...ice of America,s families by passing the Affordabl... deliver, without delay, on the promise of meaning... President and CEO of the National Alliance for Hi...
Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...Does coming from a family full of “lefties” tend t...data from two recent experiments answer in the aff... jornal Neuropsychology. Stephen D. Christman and ...rsonally left-handed to share a unique trait: Ther...
...Irregularities in hormones produced by the hypotha...asic functions as hunger and body temperature, may...hope for the 2% to 3% of the general population wh... Dr. Mario Peres, the study's lead author. // ...
...Many patients undergoing trials of new cancer trea...e likely to benefit than themselves. There can be...ease - unless there are clinical trials. Hencefort...They learned that only 60 per cent realised they m...
...New evidence about the effects of Ritalin, a drug ...pted renewed calls for research into its long-term...iversity at Buffalo, State University of New York ...ction in laboratory rats. The same gene is known t...
...Researchers in Texas find that a tai chi programme...le with arthritis. Tai chi is an ancient Chinese s...to have a wide range of health benefits. Now resea..., did 10 weeks of a tai chi programme especially d...
...Robert Tools, the recipient of the world’s first f...spital in Louisville, Ken., after suffering a seri...fter severe abdominal bleeding. He began bleeding .../ Tools, a retired telephone comp...
Other Medicine News:Health News:Research of Ritalin 2
A to Z Drug Facts, 6th Edition
2006 Lippincott's Nursing Drug Guide
...M-8 loads and unloads two centrifuges with primary...cation via Cap Recognition the tube type is determ...5 position racks into the centrifuges. Alternative...an be offered for laboratories with a smaller amou...
... different specimen in one run. Complex scanning a...l samples are sorted, decapped and archived in a v...g given sorting priorities. Optionally a Tube Type... Module can be integrated. Selectively decapping i...
Medicine Products: